Clinical Trials Directory

Trials / Unknown

UnknownNCT05201274

Baduanjin Sequential Therapy and Cardiac Function of AMI With Reduced EF After PCI

Effect of Baduanjin Sequential Therapy on the Cardiac Function and Exercise Endurance in Patients With AMI and Reduced Ejection Fraction After Primary PCI

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
140 (estimated)
Sponsor
Shenyang Northern Hospital · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Acute myocardial infarction (AMI) is one of the leading causes of death around the world, with the potential for substantial morbidity and mortality. The increasing evidence indicates that exercise training has beneficial effects on LV remodelling in post-MI patients with greater benefits occurring when training earlier following MI, among which the earliest time for rehabilitation is one week after myocardial infarction. However, the effect of Baduanjin sequential therapy for patients after one week of AMI has yet to be assessed. Therefore, the aim of this study is to assess the impact of Baduanjin sequential therapy on cardiac and physical function in patients with AMI and reduced ejection fraction after primary PCI.

Conditions

Interventions

TypeNameDescription
BEHAVIORALBaduanjin sequential therapyA detailed description of a standardized Baduanjin exercise protocol complied with the "Health Qigong Baduanjin Standard" enacted by the General Administration of Sports in 2003.
BEHAVIORALAerobic exerciseParticipants allocated to the usual exercise control group receive a closely supervised, group-format aerobic exercise program located at home or cardiac rehabilitation centre lasting 3 months. The program is consistent with the current recommended guidelines of moderate-intensity exercises for MI.

Timeline

Start date
2021-11-11
Primary completion
2023-02-11
Completion
2023-02-11
First posted
2022-01-21
Last updated
2022-01-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05201274. Inclusion in this directory is not an endorsement.